Foxo Technologies Inc (FOXO)

$0.3126

-0.01

(-2.31%)

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Foxo Technologies Inc

  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 418.0K → 10.0K (in $), with an average decrease of 30.3% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -11.29M → -3.66M (in $), with an average increase of 104.3% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 39.9% return, outperforming this stock by 135.5%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 14.3% return, outperforming this stock by 111.1%

Performance

  • $0.30
    $0.32
    $0.31
    downward going graph

    2.55%

    Downside

    Day's Volatility :5.21%

    Upside

    2.73%

    downward going graph
  • $0.25
    $9.30
    $0.31
    downward going graph

    19.35%

    Downside

    52 Weeks Volatility :97.31%

    Upside

    96.67%

    downward going graph

Returns

PeriodFoxo Technologies IncIndex (Russel 2000)
3 Months
15.65%
0.0%
6 Months
-70.97%
0.0%
1 Year
-95.6%
-0.7%
3 Years
-96.82%
-21.3%

Highlights

Market Capitalization
2.8M
Book Value
- $1.88
Earnings Per Share (EPS)
37.17
PE Ratio
0.01
Profit Margin
0.0%
Operating Margin TTM
-35070.0%
Return On Assets TTM
-61.53%
Return On Equity TTM
-1754.5%
Revenue TTM
453.0K
Revenue Per Share TTM
0.14
Quarterly Revenue Growth YOY
-28.599999999999998%
Gross Profit TTM
120.0K
EBITDA
-34.2M
Diluted Eps TTM
37.17
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY20Y/Y Change
Revenue
63.0K
-
Net Income
-8.6M
-
Net Profit Margin
-13.6K%
-
FY21Y/Y Change
Revenue
120.0K
↑ 90.48%
Net Income
-40.0M
↑ 365.62%
Net Profit Margin
-33.3K%
↓ 19700.23%
FY22Y/Y Change
Revenue
511.0K
↑ 325.83%
Net Income
-148.9M
↑ 272.2%
Net Profit Margin
-29.1K%
↑ 4198.8%
Q3 FY22Q/Q Change
Revenue
14.0K
↓ 64.1%
Net Income
-11.2M
↓ 72.75%
Net Profit Margin
-80.1K%
↑ 25421.98%
Q4 FY22Q/Q Change
Revenue
418.0K
↑ 2885.71%
Net Income
-18.3M
↑ 63.42%
Net Profit Margin
-4.4K%
↑ 75702.22%
Q1 FY23Q/Q Change
Revenue
13.0K
↓ 96.89%
Net Income
-8.1M
↓ 55.73%
Net Profit Margin
-62.4K%
↓ 58008.82%
Q2 FY23Q/Q Change
Revenue
12.0K
↓ 7.69%
Net Income
-11.3M
↑ 39.23%
Net Profit Margin
-94.1K%
↓ 31716.02%
Q3 FY23Q/Q Change
Revenue
10.0K
↓ 16.67%
Net Income
-3.7M
↓ 67.59%
Net Profit Margin
-36.6K%
↑ 57508.33%
Q4 FY23Q/Q Change
Revenue
10.0K
↑ 0.0%
Net Income
-3.7M
↑ 0.0%
Net Profit Margin
-36.6K%
↑ 0.0%
FY20Y/Y Change
Total Assets
9.4M
-
Total Liabilities
704.0K
-
FY21Y/Y Change
Total Assets
30.3M
↑ 221.56%
Total Liabilities
55.5M
↑ 7786.93%
FY22Y/Y Change
Total Assets
35.4M
↑ 16.84%
Total Liabilities
28.7M
↓ 48.31%
Q3 FY22Q/Q Change
Total Assets
45.2M
↓ 13.35%
Total Liabilities
28.3M
↓ 73.3%
Q4 FY22Q/Q Change
Total Assets
35.4M
↓ 21.68%
Total Liabilities
28.7M
↑ 1.26%
Q1 FY23Q/Q Change
Total Assets
9.9M
↓ 72.12%
Total Liabilities
9.9M
↓ 65.49%
Q2 FY23Q/Q Change
Total Assets
4.0M
↓ 59.01%
Total Liabilities
11.1M
↑ 11.85%
Q3 FY23Q/Q Change
Total Assets
3.1M
↓ 22.63%
Total Liabilities
14.2M
↑ 28.5%
Q4 FY23Q/Q Change
Total Assets
3.1M
↑ 0.0%
Total Liabilities
14.2M
↑ 0.0%
FY20Y/Y Change
Operating Cash Flow
-7.0M
-
Investing Cash Flow
-420.0K
-
Financing Cash Flow
14.1M
-
FY21Y/Y Change
Operating Cash Flow
-15.1M
↑ 113.91%
Investing Cash Flow
-355.0K
↓ 15.48%
Financing Cash Flow
14.1M
↑ 0.01%
Q3 FY22Q/Q Change
Operating Cash Flow
-4.3M
↓ 38.95%
Investing Cash Flow
-470.0K
↓ 33.05%
Financing Cash Flow
-3.3M
↓ 171.6%

Technicals Summary

Sell

Neutral

Buy

Foxo Technologies Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Foxo Technologies Inc
Foxo Technologies Inc
-4.55%
-70.97%
-95.6%
-96.82%
-96.87%
Solventum Corp
Solventum Corp
-9.19%
-9.19%
-9.19%
-9.19%
-9.19%
Veeva Systems Inc.
Veeva Systems Inc.
-11.07%
-2.46%
15.54%
-22.94%
55.88%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-2.32%
29.01%
4.75%
42.64%
42.64%
Healthequity Inc
Healthequity Inc
-2.65%
6.5%
39.89%
14.33%
6.34%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Foxo Technologies Inc
Foxo Technologies Inc
0.01
0.01
NA
0.0
-17.55
-0.62
NA
-1.88
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
65.5
65.5
1.38
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
29.07
29.07
19.9
4.29
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
124.7
124.7
2.33
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Foxo Technologies Inc
Foxo Technologies Inc
NA
$2.8M
-96.87%
0.01
0.0%
Solventum Corp
Solventum Corp
NA
$11.7B
-9.19%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.0B
55.88%
65.5
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$40.3B
42.64%
29.07
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
6.34%
124.7
5.57%

Company Information

formerly yousurance and life epigenetics. foxo bioscience is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. we also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of health and aging.

Organization
Foxo Technologies Inc
Employees
4
CEO
Mr. Mark Brian White
Industry
Healthcare

FAQs